In re Bayer Ag
146 F.3d 188, 1998.C03.125
-
- 0,99 €
-
- 0,99 €
Descrição da editora
(D.C. No. 96-cv-05650) Argued September 26, 1997 Filed June 9, 1998 OPINION OF THE COURT The promulgation of the Federal Rules of Civil Procedure, with their emphasis on securing ""the just, speedy, and inexpensive determination of every action,"" Fed. R. Civ. P. Rule 1, initiated a revolution in the litigation process in the federal courts in this country. Although those rules were not applicable to foreign litigation, they were not without influence. It was not surprising that within three decades there would be a concerted effort to liberalize the procedures in the United States for assisting foreign and international tribunals and litigants in obtaining oral and documentary evidence in the United States. Eventually this effort led to congressional action. Section 1782(a) of Title 28 of the United States Code now authorizes district courts to render assistance to foreign courts and the litigants before them in obtaining discovery from United States residents for use in foreign proceedings. Pursuant to that section, Bayer AG, a drug manufacturer organized under the laws of the Federal Republic of Germany, filed an application in the district court of New Jersey to obtain discovery from BetaChem, Inc., a New Jersey corporation, for use in a patent infringement action pending in the Court of First Instance in Spain. The district court denied the application and Bayer appeals. The question before us is whether the district court relied on inapplicable or erroneous considerations when it denied Bayer's request.